What faulty rail tracks have got to do with Parkinson’s disease

A new research project between CMIAD collaborators looks at the potential benefits of drugs that rescue axonal transport defects in Parkinson’s disease.

Following on from their promising research published recently in Nature Communications, researchers Dr Kurt De Vos from SITraN and his collaborator Dr Alex Whitworth from the Department of Biomedical Sciences at the University of Sheffield have secured MRC funding to investigate a novel therapeutic approach in Parkinson’s disease.  

Read the full article at Sheffield Institute for Translational Neuroscience